A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study. / Thyssen, Jacob P; Linneberg, Allan; Carlsen, Berit C; Johansen, Jeanne D; Engkilde, Kåre; Hansen, Torben; Pociot, Flemming; Pedersen, Oluf; Meldgaard, Michael; Szecsi, Pal B; Stender, Steen; Menné, Torkil.

In: BMJ Open, Vol. 1, No. 1, 01.01.2011, p. e000062.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Thyssen, JP, Linneberg, A, Carlsen, BC, Johansen, JD, Engkilde, K, Hansen, T, Pociot, F, Pedersen, O, Meldgaard, M, Szecsi, PB, Stender, S & Menné, T 2011, 'A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study', BMJ Open, vol. 1, no. 1, pp. e000062. https://doi.org/10.1136/bmjopen-2011-000062

APA

Thyssen, J. P., Linneberg, A., Carlsen, B. C., Johansen, J. D., Engkilde, K., Hansen, T., Pociot, F., Pedersen, O., Meldgaard, M., Szecsi, P. B., Stender, S., & Menné, T. (2011). A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study. BMJ Open, 1(1), e000062. https://doi.org/10.1136/bmjopen-2011-000062

Vancouver

Thyssen JP, Linneberg A, Carlsen BC, Johansen JD, Engkilde K, Hansen T et al. A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study. BMJ Open. 2011 Jan 1;1(1):e000062. https://doi.org/10.1136/bmjopen-2011-000062

Author

Thyssen, Jacob P ; Linneberg, Allan ; Carlsen, Berit C ; Johansen, Jeanne D ; Engkilde, Kåre ; Hansen, Torben ; Pociot, Flemming ; Pedersen, Oluf ; Meldgaard, Michael ; Szecsi, Pal B ; Stender, Steen ; Menné, Torkil. / A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study. In: BMJ Open. 2011 ; Vol. 1, No. 1. pp. e000062.

Bibtex

@article{c35b49127e4d4321ae20a830284bcfa9,
title = "A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study",
abstract = "Background Filaggrin proteins are located in the skin and prevent epidermal water loss and impede the entry of micro-organisms, allergens and chemicals. Filaggrin null mutations are strongly associated with ichthyosis vulgaris and atopic dermatitis. Objective The authors aimed to investigate the association between filaggrin null mutations, atopic dermatitis and diabetes. Design A random sample of 3335 adults from the general population in Denmark was filaggrin-genotyped for R501X and 2282del4 null-mutations and questioned about atopic dermatitis and diabetes. Furthermore, two independent study populations of patients with type 1 (n=104) or 2 (n=774) diabetes were genotyped. Results In a crude data analysis, a positive association was detected between the filaggrin null genotype and, respectively, subjects from the general population who reported diabetes (p=0.04) and patients with established type 2 diabetes (p=0.073). Adjustment for age and gender resulted in significant associations for patients with type 2 diabetes (p=0.048) and subjects with self-reported diabetes (p=0.032). Conclusions Adult Danes with a filaggrin null genotype had a significantly increased prevalence of self-reported diabetes. This finding was replicated when an independent sample of Danish patients with established type 2 diabetes was compared with control subjects from the general population.",
author = "Thyssen, {Jacob P} and Allan Linneberg and Carlsen, {Berit C} and Johansen, {Jeanne D} and K{\aa}re Engkilde and Torben Hansen and Flemming Pociot and Oluf Pedersen and Michael Meldgaard and Szecsi, {Pal B} and Steen Stender and Torkil Menn{\'e}",
year = "2011",
month = jan,
day = "1",
doi = "10.1136/bmjopen-2011-000062",
language = "English",
volume = "1",
pages = "e000062",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "1",

}

RIS

TY - JOUR

T1 - A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study

AU - Thyssen, Jacob P

AU - Linneberg, Allan

AU - Carlsen, Berit C

AU - Johansen, Jeanne D

AU - Engkilde, Kåre

AU - Hansen, Torben

AU - Pociot, Flemming

AU - Pedersen, Oluf

AU - Meldgaard, Michael

AU - Szecsi, Pal B

AU - Stender, Steen

AU - Menné, Torkil

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Background Filaggrin proteins are located in the skin and prevent epidermal water loss and impede the entry of micro-organisms, allergens and chemicals. Filaggrin null mutations are strongly associated with ichthyosis vulgaris and atopic dermatitis. Objective The authors aimed to investigate the association between filaggrin null mutations, atopic dermatitis and diabetes. Design A random sample of 3335 adults from the general population in Denmark was filaggrin-genotyped for R501X and 2282del4 null-mutations and questioned about atopic dermatitis and diabetes. Furthermore, two independent study populations of patients with type 1 (n=104) or 2 (n=774) diabetes were genotyped. Results In a crude data analysis, a positive association was detected between the filaggrin null genotype and, respectively, subjects from the general population who reported diabetes (p=0.04) and patients with established type 2 diabetes (p=0.073). Adjustment for age and gender resulted in significant associations for patients with type 2 diabetes (p=0.048) and subjects with self-reported diabetes (p=0.032). Conclusions Adult Danes with a filaggrin null genotype had a significantly increased prevalence of self-reported diabetes. This finding was replicated when an independent sample of Danish patients with established type 2 diabetes was compared with control subjects from the general population.

AB - Background Filaggrin proteins are located in the skin and prevent epidermal water loss and impede the entry of micro-organisms, allergens and chemicals. Filaggrin null mutations are strongly associated with ichthyosis vulgaris and atopic dermatitis. Objective The authors aimed to investigate the association between filaggrin null mutations, atopic dermatitis and diabetes. Design A random sample of 3335 adults from the general population in Denmark was filaggrin-genotyped for R501X and 2282del4 null-mutations and questioned about atopic dermatitis and diabetes. Furthermore, two independent study populations of patients with type 1 (n=104) or 2 (n=774) diabetes were genotyped. Results In a crude data analysis, a positive association was detected between the filaggrin null genotype and, respectively, subjects from the general population who reported diabetes (p=0.04) and patients with established type 2 diabetes (p=0.073). Adjustment for age and gender resulted in significant associations for patients with type 2 diabetes (p=0.048) and subjects with self-reported diabetes (p=0.032). Conclusions Adult Danes with a filaggrin null genotype had a significantly increased prevalence of self-reported diabetes. This finding was replicated when an independent sample of Danish patients with established type 2 diabetes was compared with control subjects from the general population.

U2 - 10.1136/bmjopen-2011-000062

DO - 10.1136/bmjopen-2011-000062

M3 - Journal article

C2 - 22021744

VL - 1

SP - e000062

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 1

ER -

ID: 35312621